Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.

Phase 2

Pfizer

Nifedipine
Sitaxsentan